|
Eosinophilic Asthma: Reducing Exacerbations and Steroid Use
Medscape This study focused on the use of a novel humanized monoclonal antibody against interleukin-5 (IL-5) in patients with severe eosinophilic-related asthma. We all take care of patients who, despite optimal inhaled therapy and the use of other oral agents … |
View full post on asthma – Google News